For citations:
Ametov A.S., Bely P.A., Zaslavskaya K.Y., Rogozhina E.A., Shcherbakova V.S., Kazaishvili Y.G., Taganov A.V., Bodrova T.G., Mishchenko E.S., Koryanova K.N., Shcherbakova L.I. Comparative analysis of pharmacokinetic parameters, bioequivalence, safety, tolerability and immunogenicity of semaglutide-based drug for the treatment of obesity. Pharmacy & Pharmacology. 2024;12(3):231-246. https://doi.org/10.19163/2307-9266-2024-12-3-231-246